Home > Healthcare & Medical Devices > Cardiopulmonary Bypass Pumps Market
Cardiopulmonary Bypass Pumps Market size will substantially grow between 2023 and 2032 due to the growing burden of respiratory and cardiovascular diseases worldwide.
Additionally, the emergence of the COVID-19 pandemic spurred the expansion of the cardiopulmonary bypass pumps industry with the thriving favorable government support pertaining to the development of innovative products despite the pandemic-driven supply chain issues.
Based on product, the roller cardiopulmonary bypass pumps industry is estimated to register significant revenue gains over 2032. The value can be attributed to their ease of use, affordability, and reliability of flow calculation. These advanced tools are designed with microprocessors to enable blood flow based on the roller-head speed and the tubing diameter of the circuit.
With regards to application, the cardiopulmonary bypass pumps market share from lung transplant operations is expected to rise significantly over 2032. Cardiopulmonary bypass pumps are increasingly used in en-bloc and double-bloc lung transplantation driven by the surging number of transplantation procedures performed each year. The increasing prevalence of chronic respiratory diseases and the growing concerns associated with pulmonary failures will propel the demand for advanced pulmonary pumps, subsequently driving the market growth.
In terms of end-use, hospitals are projected to account for substantial share of the cardiopulmonary bypass pumps industry by 2032. Hospitals are investing heavily in modern cardiopulmonary bypass devices as they enable continuous monitoring of temperature, circuit pressure, and blood parameters to ensure safety. Due to the growing patient pool of cardiovascular diseases and the massive healthcare spending worldwide, several private and public initiatives are helping hospitals deploy next-generation medical equipment and machines for better patient outcomes.
Regionally, North America cardiopulmonary bypass pumps market size is set to expand at a substantial rate from 2023-2032 driven by the increasing prevalence of cardiovascular illnesses. According to the Centers for Disease Control & Prevention (CDC), approximately 659,000 deaths are caused by heart diseases each year. Moreover, the presence of supportive government initiatives and favorable reimbursement policies will fuel industry expansion across the region. The U.S. and Canada are also placing hefty investments in extensive research activities to boost innovation and technological advancements along with collaborations among healthcare companies. These factors are likely to assist in the regional market expansion.
The cardiopulmonary bypass pumps market comprises players, such as Olympus Corporation, Terumo Corporation, LivaNova, Medtronic, Maquet (Getinge), and BraileBiomedica. These companies are entering strategic agreements and deals to strengthen their competitive position.